CTPI-2

Cat. No.: 0225LY-1455

Appearance: Solid

Purity: ≥97%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: CTPI-2 is an inhibitor of the mitochondrial citrate carrier SLC25A1 (KD: 3.5 μM) that combats obesity and NASH by reversing steatosis, reducing tissue inflammation, and halting glycolysis.

Synonym: 68003-38-3; 2-(4-chloro-3-nitrobenzenesulfonamido)benzoic acid; Benzoic acid, 2-[[(4-chloro-3-nitrophenyl)sulfonyl]amino]-; 2-(4-chloro-3-nitro-benzenesulfonylamino)-benzoic acid; 2-[(4-chloro-3-nitro-phenyl)sulfonylamino]benzoic acid; SLC25A1 inhibitor CTPI-2; 2-[(4-chloro-3-nitrophenyl)sulfonylamino]benzoic acid; 2-(4'-Chloro-3'-nitrobenzenesulfonamido)benzoic acid; 2-[(4-chloro-3-nitrophenyl)sulphonyl]anthranilic acid; Benzoic acid, 2-(((4-chloro-3-nitrophenyl)sulfonyl)amino)-; 2-(4-Chloro-3-nitrophenylsulfonamido)benzoic acid; 2-((4-Chloro-3-nitrophenyl)sulfonyl)anthranilic acid; 2-((4-Chloro-3-nitrophenyl)sulphonyl)anthranilic acid

CAS No.: 68003-38-3

Compound CID: 106350

Formula: C₁₃H₉ClN₂O₆S

Formula Weight: 356.74

Specification

Targets&IC50: SLC25A1: 3.5 μM (KD)

Relative Density: 1.66 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: CTPI-2 can be used in metabolic oncology to investigate the inhibition of mitochondrial citrate carriers and their role in suppressing tumor growth.